1 / 75

High Altitude: Physiology & Illness

Military Sports Medicine Fellowship. High Altitude: Physiology & Illness. “Every Warrior an Athlete”. Kevin deWeber , MD, FAAFP, FACSM COL, US Army Director, Military Sports Medicine Fellowship 2012. Objectives. Outline strategies to optimize exercise performance at altitude

aysha
Télécharger la présentation

High Altitude: Physiology & Illness

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Military Sports Medicine Fellowship High Altitude:Physiology & Illness “Every Warrior an Athlete” Kevin deWeber, MD, FAAFP, FACSM COL, US Army Director, Military Sports Medicine Fellowship 2012

  2. Objectives • Outline strategies to optimize exercise performance at altitude • Review pathophysiology of high altitude illness (HAI) • Review the types of HAI and how they are treated • Review factors predisposing to HAI • Discuss factors in return-to-altitude decisions after HAI

  3. Preview • Acclimatization and slow ascent are powerful preventives for High Altitude Illness • Acclimatize properly • Spend 2-3 nights at 2500-3000m before ascent • Slow ascent • Ascend < 500 m/day of sleeping altitude • Rest day every 3-4 days • Prophylactic meds advised if unable to comply • Acetazolamide is powerful to prevent most HAI • Dexamethasone powerfully treats serious HAI

  4. Environment at high altitude(>1500 m or 4920 ft) • Barometric pressure decreases • Partial pressure of oxygen decreases • RESULT: “Hypobaric Hypoxia” • Lower alveolar O2 leads to lower SaO2

  5. Ft. Carson, CO, ~6500 ft Pikes Peak, 14,110 ft (4300 m) US Air Force Academy, ~7,000 ft

  6. Effects of High Altitude Exposure • Decreased exercise capacity • +/- 1% decrease in VO2max per 100m above 1500m • Individual variability • MECHANISMS: • Peripheral hypoxia • Cerebral hypoxia  peripheral inhibition • High altitude illness • Individual variability

  7. Acclimatization = body’s adaptation to hypobaric hypoxia

  8. Acclimatization • Immediate (minutes to hours) • ↑ Sympathetic tone ↑ HR & CO • ↑ Ventilation  ↑ PaO2 and↓ PaCO2  ↑ pH • Renal bicarbonate diuresis (to balance pH) • ↑ Pulmonary artery pressure ↑ O2 absorption • Delayed (days to weeks) • Erythropoietin  ↑ RBC production, hemoconcentration • Remodeling of pulmonary arterioles

  9. Implications for Athletes • Endurance performance of lowlanders is impaired at altitude • Mexico City Olympics 1968, elev 2240m • Sprint & projectile performance might be enhanced • Thinner air • Altitude training enhances altitude performance • Altitude training MAY affect sea-level performance Bob Beaman shatters world high jump record by 22”

  10. Training Strategies to Optimize Altitude Performance • Live High – Train High (LHTH) • “classic” method • Live High - Train Low (LHTL) • Natural (descend for training) • Artificial live-high • Long-continuous low-O2 • Brief-continuous low-O2 • Brief-Intermittent low O2 • Live Low – Train High in low-O2 Application of Altitude/Hypoxic Training by Elite Athletes, Med Sci Sports Exer 2007

  11. Sea-level exercise performance following adaptation to hypoxia: a meta-analysis Bonetti DL, Hopkins WG Sports Med 2009

  12. Classic Live High – Train High (LHTH) • Sub-elite athletes: • LIKELY GOOD FOR VO2MAX (?placebo) • Elite: BAD • Collegiate runners returned to SL 3-8% detrained in 1- and 2-mile times

  13. Live High - Train Low (LHTL) • LH: Deer Valley, UT 2500m, 22 h/d • TL: SLC, UT 1250m, 2 h/d • Logistically difficult • Elite athletes: POSSIBLE benefit (4% +/- 3.7%) • Sub-elite: LIKELY benefit (4.2% +/- 2.9%)

  14. Artificial LH – TLLong-continuous hypoxia, 8-18 hrs • Live at sea level but in hypoxic environment • Nitrogen dilution (Scandinavia) • Oxygen filtration (OTC Chula Vista, CA) • Train at normoxic sea level • Unproven but assumed altitude advantage • Results equivocal at sea level performance • Sub-elite: POSSIBLE 1.4% +/- 2.0% • Elite: UNCLEAR

  15. Artificial LH - TLBrief-continuous hypoxia, 1.5-5 hrs • Sub-elite: UNCLEAR • Elite: UNCLEAR

  16. Artificial LH – TLBrief-Intermittent, < 1.5 hrs ea • Sub-elite: VERY LIKELY (2.6% +/- 1.2%) • Elite: UNCLEAR

  17. Live Low – Train High • UNCLEAR

  18. Live Low - Train High Methods - IHE: intermittent hypoxic exposure - IHT: intermittent hypoxic training • Dosing variation (hrs/day, # weeks) • Ventilatory benefits >> hematologic • Effective for pre-acclimatization, not performance • ? Tissue effect (increased skeletal muscle mitochondrial density, capillary to fiber ratio, fiber area)

  19. How long do benefits of altitude training last after cessation? • 3-6 weeks upon return to sea level

  20. Altitude Illnesses (Failure to Acclimatize)

  21. Cerebral Syndromes • Acute Mountain Sickness (AMS) • High Altitude Cerebral Edema (HACE) mild AMS moderate AMS HACE • Pulmonary Syndrome • High Altitude Pulmonary Edema (HAPE) • Importance • HACE and HAPE can be fatal

  22. Acute Mountain Sickness (AMS) • Occurs above 1500 m (4920 ft) • More common above 2500 m • Defined as HEADACHE plus one or more symptom: • Anorexia, nausea or vomiting • Fatigue or weakness • Dizziness or lightheadedness • Difficulty sleeping • Headache alone: High-Altitude Headache • Gabapentin, Acetazolamide, or Ibuprofen preventative • J Neurol Neurosurg Psychiat 2008 • Cephalgia 2007 • Wilderness Environ Med 2010

  23. Effects of AMS on performance • Mild: annoyance only • Moderate: impaired concentration, memory, speech, and physical performance; • Can be disabling • Subtle abnormalities visible on MRI • Effects can last weeks

  24. High Altitude Cerebral Edema(HACE) • AMS symptoms plus ALTERED L.O.C. and ATAXIA • Other neuro findings possible • Coma develops • Death results if untreated • Pathophysiology • altered cerebral vascular permeability leads to brain swelling • MRI: cerebral edema, lesions of corpus callosum

  25. High Altitude Pulmonary Edema(HAPE) • Defined by two pulmonary symptoms… • Cough, dyspnea at rest, exercise intolerance, chest tightness/congestion… • and two pulmonary signs… • Crackles, wheezing, cyanosis, tachypnea, tachycardia • Most common cause of death among HAI • 50% mortality rate if not treated quickly

  26. High Altitude Pulmonary Edema(HAPE) • CXR findings • Blotchy fluffy infiltrates • Pathophysiology Hypoxia  pulmonary artery hypertension • alveolar damage  edema and hemorrhage into alveoli

  27. Risk factors for HAI • Rapid gain in altitude • Prior history of HAI • genetic factors involved • Alcohol, sedatives • Strenuous exercise • HAPE: cold ambient temperature, resp. infxn

  28. HAI Protective Factors • Residence at elevation >900 m (2950 ft) • Slow gain in elevation • <500 m (1640 ft) per day in sleeping elevation • Genetic factors • Physical fitness NOT protective

  29. Treating HAI:General Principles • Rest, halt ascent • Descend • Moderate AMS: >500 m (1640 ft) • HACE/HAPE: > 1000 m (3280 ft) • Oxygen if available (keep Pox >90%) • Keep warm (esp. for HAPE)

  30. Treating HAI:Medications • Acetazolamide • Speeds acclimatization • Treats moderate AMS & HACE • Dose: 125-250 mg BID • Anti-emetics • Non-narcotic analgesics

  31. Meds (cont.) • Dexamethasone • Decreases cerebral edema • Treats moderate AMS and HACE • Prevents AMS, HACE, HAPE • Dose • 8-16 mg/d in div doses

  32. Meds (cont.) • Nifedipine • Decreases pulmonary artery pressure • Prevents HAPE • Dose: 30 mg SR BID (one study) • NOT EFFECTIVE FOR TREATMENT (one study)

  33. Meds (cont.) • Salmeterol • Decreases alveolar fluid transport • May prevent HAPE • Dose: 125 mcg inhaled BID

  34. Meds (cont.) • Tadalafil • Dilates pulmonary vessels, prevents pulmonary hypertension • May prevent HAPE • Dose: 10 mg po BID

  35. Treatment of AMS • Descend > 500 m (1640 ft) OR • Rest 1-2 days at same altitude • Oxygen 12-24 hours, if available • Symptomatic treatment with analgesics, anti-emetics • Consider acetazolamide 125-250 mg po BID

  36. Treatment of HACE • Immediate descent > 1000 m and hospitalize • Oxygen to maintain SaO2 >90% • Dexamethasone—8 mg PO/IM/IV initially followed by 4 mg QID • Consider adding acetazolamide • Portable hyperbaric therapy if descent impossible

  37. Portable Hyperbaric Chambers

  38. Treatment of HACE (cont.) • Management of coma • Bladder catheterization • Airway control • Diagnostic studies • CXR to rule out concurrent HAPE • MRI to rule out other conditions

  39. Recovery from HACE:highly variable • 1-3 days for symptoms to resolve • Days to 12 weeks for neuropsychological function to normalize • 3-4 weeks for papilledema to resolve • Days to 5 weeks for MRI to normalize

  40. Treatment of HAPE • Immediate descent >1000 m • Oxygen to keep SaO2 >90%. • If descent/O2 not immediately available… • Portable hyperbaric therapy • Nifedipine 30 mg extended release BID (avoid if concomitant HACE) and • Salmeterol 125 mcg inhaled

  41. Treatment of HAPE (cont.) • Admit if: • >4L/min O2 requirement • Elderly, very young • Concomitant HACE or co-morbid cardio-pulmonary disease • Dexamethasone if concomitant HACE • Low-flow outpatient O2for others; check daily

  42. Recovery from HAPE • Variable; little evidence in literature • May take 2 weeks to recover strength • Resume some activity when SaO2 > 90% without supplemental O2 • Remaining at some altitude fosters acclimatization via pulmonary arteriolar remodeling

  43. PREVENTION OFHAI

  44. Prevention of HAI:General Principles • Proper acclimatization protocols are paramount • Avoid abrupt ascent to >3000 m (9843 ft) • Spend 2-3 nights at 2500-3000 m before ascending further • Ascend no more than 500 m (1640 ft) per day in sleeping altitude when >2500 m (8200 ft) • Rest day every 3-4 days

  45. “Effect of ascent protocol on AMS and success at Muztagh Ata, 7546 m”Bloch KE at al, High Alt Med Biol2009 • Randomized, controlled trial, 48 climbers • 15 day vs 19 day ascent • 15 day: 3d at 3000, 500m/d x 2d, then rest day • 19 day: 4d at 3000, 500m/d x 3d, then rest day • Slow (19d): • OddsRatio 9.5 for reaching high camp w/o AMS • Fewer days of AMS (p<.04) • Lower AMS scores (p<.008)

  46. Prevention of HAI:Other protective factors • Living at altitude >2200 m days to weeks • >5days above 3000m last 2 months --> less AMS (Schneider et al, MSSE 2002) • Intermittent Hypoxic Exposure (IHE) 4hr/d x15d  less AMS @4300 m • Beidleman et al, Clin Sci 2004

  47. “Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate” Schneider M et al. Med Sci Sports Exerc 2002

More Related